Stocks › AXGN

Axogen, Inc.

AXGN·Nasdaq·United States United States·USD
$55.75
-0.60 (-1.06%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
AXGN
Axogen, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AXGNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of AXGN by members of U.S. Congress · 2 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Donna ShalalaDonna ShalalaHouse · D · FL AXGNAxogen, Inc. · Stock Purchase
$1,001 - $15,000
Apr 27, 2020 Apr 16, 2019 Filing ↗
Donna ShalalaDonna ShalalaHouse · D · FL AXGNAxogen, Inc. · Stock Sale
$1,001 - $15,000
Apr 27, 2020 Jun 24, 2019 Filing ↗

Whale Activity

Position changes in AXGN reported for 2026-09-30 by 292 institutional filers
Increased: 100New: 34Held: 29Decreased: 76Closed: 40No prior filing: 13
  • Increased100
  • New34
  • Held29
  • Decreased76
  • Closed40
  • No prior filing13
FilerSharesValueChange
BlackRock, Inc.4.6M$192.0Mincreased
First Light Asset Management, LLC3.7M$156.7Mincreased
FMR LLC2.6M$110.6Mincreased
Divisadero Street Capital Management, LP2.5M$104.6Mincreased
VANGUARD CAPITAL MANAGEMENT LLC2.4M$102.0Mincreased
Hood River Capital Management LLC2.3M$98.3Mincreased
WELLINGTON MANAGEMENT GROUP LLP1.8M$77.0Mincreased
Polar Capital Holdings Plc1.8M$75.8Mincreased
MORGAN STANLEY1.8M$75.0Mdecreased
Artemis Investment Management LLP1.8M$74.7Mincreased
RTW INVESTMENTS, LP1.7M$69.6Mincreased
GEODE CAPITAL MANAGEMENT, LLC1.6M$69.2Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by AXGN insiders, by quarter · Form 4
-500.0K-250.0K0250.0K500.0K2025 Q1: -20.1K2025 Q12025 Q2: -74.0K2025 Q22025 Q3: -1,1372025 Q32025 Q4: -480.5K2025 Q42026 Q1: -5,2212026 Q12026 Q2: -38.0K2026 Q22026 Q3: -98.5K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

811 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
TYNDALL JOSEPH A.Director Sale −3,500 $49.70 $174K Sep 2, 2026 Form 4 ↗
Wendell Amy McBrideDirector Sale −13.4K $48.42 $647K Aug 11, 2026 Form 4 ↗
Wendell Amy McBrideDirector Option exercise +13.4K $14.85 $198K Aug 11, 2026 Form 4 ↗
Began Marc AEVP & General Counsel Sale −67.5K $47.35 $3.2M Aug 10, 2026 Form 4 ↗
Began Marc AEVP & General Counsel Option exercise +67.5K $8.16 $551K Aug 10, 2026 Form 4 ↗
Weiler Kathy JohnsonDirector Sale −14.2K $45.30 $641K Aug 7, 2026 Form 4 ↗
JOHNSON JOHNDirector Option exercise +14.2K $0.00 $0 Jun 19, 2026 Form 4 ↗
Wendell Amy McBrideDirector Option exercise +14.2K $0.00 $0 Jun 19, 2026 Form 4 ↗
Levine Alan MDirector Option exercise +14.2K $0.00 $0 Jun 19, 2026 Form 4 ↗
Weiler Kathy JohnsonDirector Option exercise +14.2K $0.00 $0 Jun 19, 2026 Form 4 ↗
THOMAS PAULDirector Option exercise +18.9K $0.00 $0 Jun 19, 2026 Form 4 ↗
TYNDALL JOSEPH A.Director Option exercise +14.2K $0.00 $0 Jun 19, 2026 Form 4 ↗
Burke William P. Mr.Director Option exercise +14.2K $0.00 $0 Jun 19, 2026 Form 4 ↗
Wendell Amy McBrideDirector Sale −1,647 $42.60 $70K May 8, 2026 Form 4 ↗
Wendell Amy McBrideDirector Option exercise +1,647 $14.85 $24K May 8, 2026 Form 4 ↗
JOHNSON JOHNDirector Sale −11.1K $43.26 $478K May 7, 2026 Form 4 ↗
JOHNSON JOHNDirector Option exercise +11.1K $7.04 $78K May 7, 2026 Form 4 ↗
Weiler Kathy JohnsonDirector Sale −16.3K $44.09 $721K May 7, 2026 Form 4 ↗
Weiler Kathy JohnsonDirector Option exercise +16.3K $6.95 $114K May 7, 2026 Form 4 ↗
Kemp JensChief Marketing Officer Sale −4,000 $43.44 $174K May 7, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding AXGN · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.6M$73.7M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
1.4M$63.5M0.08%Jun 30, 2026
Hood River Small-Cap Growth Fund
Manager Directed Portfolios
687.9K$31.8M0.48%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
609.7K$28.2M0.03%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.588.2K$27.2M0.18%Jun 30, 2026
BARON DISCOVERY FUND
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)
532.9K$24.6M1.35%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
575.5K$24.3M0.07%Jul 31, 2026
iShares Russell 2000 Growth ETF
iShares Trust
485.9K$22.4M0.15%Jun 30, 2026
Fidelity Stock Selector Small Cap Fund
Fidelity Capital Trust
526.0K$22.2M0.30%Jul 31, 2026
VANGUARD EXPLORER FUND428.1K$18.1M0.08%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list AXGN's shares (CUSIP 05463X106), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Morgan StanleySCHEDULE 13G/A · passive (13G) · 1.7M shares2.8%
    Nov 13, 2026 · ↗
  • Divisadero Street Capital, LLCSCHEDULE 13G · passive (13G) · 4.0M shares6.8%
    Oct 2, 2026 · ↗
  • Divisadero Street Partners GP, LLCSCHEDULE 13G · passive (13G) · 3.4M shares5.9%
    Oct 2, 2026 · ↗
  • Divisadero Street Partners, L.P.SCHEDULE 13G · passive (13G) · 3.4M shares5.9%
    Oct 2, 2026 · ↗
  • William ZolezziSCHEDULE 13G · passive (13G) · 4.0M shares6.8%
    Oct 2, 2026 · ↗
  • Divisadero Street Capital Management, LPSCHEDULE 13G · passive (13G) · 4.0M shares6.8%
    Oct 2, 2026 · ↗
  • Mathew P. ArensSCHEDULE 13G/A · passive (13G) · 4.1M shares7.6%
    Aug 14, 2026 · ↗
  • First Light Asset Management, LLCSCHEDULE 13G/A · passive (13G) · 3.7M shares7.0%
    Aug 14, 2026 · ↗
  • Vanguard Capital ManagementSCHEDULE 13G/A · passive (13G) · 2.7M shares5.0%
    Jul 31, 2026 · ↗
  • Mathew P. ArensSCHEDULE 13G/A · passive (13G) · 3.6M shares6.8%
    May 7, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming axogen as client
$0$25K$50K$75K$100K2023 Q1: $10K2023 Q2: $10K2023 Q3: $10K2023 Q4: $10K20232024 Q1: $10K2024 Q2: $10K2024 Q3: $10K2024 Q4: $15K20242025 Q1: $15K2025 Q2: $15K2025 Q3: $30K2025 Q4: $30K20252026 Q1: $30K2026 Q2: $15K2026 Q3: $15K2026
  • LKB STRATEGIES LLCAXOGEN, INC. · 2026 Q3 · HCR$15K
    Filing ↗
  • LKB STRATEGIES LLCAXOGEN, INC. · 2026 Q2 · HCR$15K
    Filing ↗
  • LKB STRATEGIES LLCAXOGEN, INC. · 2026 Q1 · HCR$15K
    Filing ↗
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.AXOGEN CORPORATION · 2026 Q1 · HCR$15K
    Filing ↗
  • LKB STRATEGIES LLCAXOGEN, INC. · 2025 Q4 · HCR$15K
    Filing ↗

Government Contracts

Federal awards to Axogen, Inc. · USAspending

No federal contract awards found for Axogen, Inc..

U.S. Patents

Recent USPTO applications naming Axogen, Inc.

No USPTO patent applications found for Axogen, Inc..

Annual Financials

From AXGN's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$225.2M$187.3M$159.0M$138.6M$127.4M
Operating income-$7.8M-$3.3M-$21.5M-$29.7M-$25.4M
Net income-$15.7M-$10.0M-$21.7M-$28.9M-$27.0M
Diluted EPS-$0.34-$0.23-$0.51-$0.69-$0.65
Operating cash flow$812K$4.5M-$5.7M-$16.1M-$13.4M
Cash and equivalents$35.5M$27.6M$31.0M$15.3M$32.8M
Total assets$221.7M$203.7M$196.8M$195.4M$208.0M
Total liabilities$92.8M$99.8M$101.2M$94.4M$95.5M
Shareholders' equity$128.8M$103.9M$95.7M$101.0M$112.5M

As Axogen, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in AXGN's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 9.01Reg FD disclosureNov 9, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureOct 28, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureOct 1, 2026
    EDGAR ↗
  • 8-K/A · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureSep 10, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 8.01, 9.01Material agreement · Reg FD disclosure · Other eventsSep 10, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 29, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 23, 2026
    EDGAR ↗

About Axogen, Inc.

From SEC EDGAR company records
Industry (SIC 3845)Electromedical & Electrotherapeutic Apparatus
SectorHealthcare
HeadquartersALACHUA, FL
IncorporatedMN
Former namesLECTEC CORP /MN/